药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Arformoterol
Givinostat
The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Givinostat.
Arformoterol
Temefos
The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Temefos.
Arformoterol
Prulifloxacin
The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Prulifloxacin.
Arformoterol
CUDC-907
The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with CUDC-907.
Arformoterol
Pazufloxacin
The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Pazufloxacin.
Arformoterol
Bilastine
The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Bilastine.
Arformoterol
Difloxacin
The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Difloxacin.
Arformoterol
Sarafloxacin
The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Sarafloxacin.
Arformoterol
Phosmet
The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Phosmet.
Arformoterol
Orbifloxacin
The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Orbifloxacin.
Arformoterol
Fenthion
The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Fenthion.
Arformoterol
Famphur
The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Famphur.
Arformoterol
Dichlorvos
The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Dichlorvos.
Arformoterol
Coumaphos
The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Coumaphos.
Arformoterol
Acrivastine
The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Acrivastine.
Arformoterol
Olodaterol
The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Olodaterol.
Arformoterol
Flumequine
The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Flumequine.
Arformoterol
Chlorcyclizine
The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Chlorcyclizine.
Arformoterol
Eribulin
The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Eribulin.
Arformoterol
Geranylgeranyl diphosphate
The risk or severity of QTc prolongation can be increased when Geranylgeranyl diphosphate is combined with Rilpivirine.